SIBN 12.56 Stock Price SI-BONE, Inc.
Range: | 11.7-21.7 | Vol Avg: | 373818 | Last Div: | 0 | Changes: | 0.27 |
Beta: | 1.23 | Cap: | 0.53B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Wed Oct 17 2018 | Empoloyees: | 344 |
CUSIP: | 825704109 | CIK: | 0001459839 | ISIN: | US8257041090 | Country: | US |
CEO: | Ms. Laura A. Francis MBA | Website: | https://si-bone.com |
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.